Lowe, GB
Andrew John Lowe, West Yorshire GB
Patent application number | Description | Published |
---|---|---|
20100085496 | OPTICAL PROCESSING - An optical processing system is described that allows rapid evaluation of derivatives and partial derivatives by means of optical Fourier transformation. In embodiments, separate filtering steps are used to provide phase and amplitude changes. | 04-08-2010 |
Anthony Cyril Lowe, Braishfield GB
Patent application number | Description | Published |
---|---|---|
20090322794 | DISPLAY WITH IMPROVED UNIFORMITY - An image display is disclosed comprising an image display device with a light emitting surface having an array of picture elements; a light guide formed from a plurality of light transmission guides with the input to each light transmission guide being provided by a sub-array of a plurality of picture elements from the light emitting surface of the image display device and luminance correction means to assign a colour component value and a dither fraction value to each sub-array of a plurality of picture elements on the light emitting surface of the image display device. Assigning a colour component value ( | 12-31-2009 |
Antony Joseph Frank Lowe, South Gloucestershire GB
Patent application number | Description | Published |
---|---|---|
20100315414 | DISPLAY OF 3-DIMENSIONAL OBJECTS - A system for displaying 3-dimensional images is provided. The system comprises a monitor, a rendering module arranged to provide image data for display by the monitor, a point-of-view module for determining the position of a viewer relative to the monitor, wherein the output of said rendering module is dependent on the determined position of the viewer relative to the monitor and a polar correction module arranged to adjust the brightness of one or more pixels of the monitor dependent on the position of the viewer relative to the monitor. | 12-16-2010 |
Chris Lowe, St. Neots GB
Patent application number | Description | Published |
---|---|---|
20110004761 | VIRAL FILE TRANSFER - A method of distributing data between mobile devices while retaining control of that data. In particular, Digital Rights Management parameters are monitored and modified to control the distribution, and distribution is only permitted to devices which are approved or authorized. Mechanisms are provided for validating the identity of devices requesting transmission of the file. | 01-06-2011 |
Chris Lowe, Cambridgeshire GB
Patent application number | Description | Published |
---|---|---|
20100174834 | Software Install Automation - Method and peripheral device to facilitate the installation of software on a host device to allow communication between that host device and a peripheral device. On connection to a host device a peripheral device presents in a first mode. In the first mode the device identifies itself as a Human Interaction Device and transmits information to the host device to facilitate the installation of the software. Subsequently the peripheral device operates in a second mode in which it identifies itself according to its real function. | 07-08-2010 |
20110078275 | SHARING OF ACCESS TO A STORAGE DEVICE - A method and system for sharing access to a storage device. Two processing devices are connected to a storage device interface. The processing devices are interconnected to allow communication with regard to access to the storage device interface. Access to the storage device interface is controlled by the first and second processing devices exchanging signals. Embodiments of the invention may be a mobile device configured to play audio files from a memory card connected to the mobile device. A communications link may be established to a remote device for the transfer of data between devices. | 03-31-2011 |
Christopher Lowe, Saffron Walden GB
Patent application number | Description | Published |
---|---|---|
20130293439 | ANTENNA DEVICE - An antenna for wireless telecommunication comprises a piezoelectric material layer, the piezoelectric material layer being formed such that when an electromagnetic wave is applied thereto, the first piezoelectric material layer is excited at the frequency of the electromagnetic wave. The antenna also comprises an acoustic cavity layer arranged to collect the acoustic energy received from the first piezoelectric layer and first and second electrode layers positioned on either side of the acoustic cavity layer, the electrode layers being arranged to transfer electrical energy to and from both the piezoelectric material layer and the acoustic cavity layer. | 11-07-2013 |
Christopher Lowe, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20100305066 | Fused Thiophene Derivatives as Kinase Inhibitors - A series of 5,6-dihydro-1-benzothiophen-7(4H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. | 12-02-2010 |
20110105508 | QUINOXALINE AND QUINOLINE DERIVATIVES AS KINASE INHIBITORS - A series of heteroaryl-substituted quinoxaline and quinoline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. | 05-05-2011 |
Christopher Kevan Lowe, St. Neots GB
Patent application number | Description | Published |
---|---|---|
20150282136 | Scheduling in a Communication Network - A scheduler for allocating communication resources to terminals that are operating in a communication network comprising a plurality of cells, the scheduler comprising a macro-scheduler configured to, for the plurality of cells, allocate the communication resources available to each cell between the terminals in that cell using a first scheduling algorithm and a micro-scheduler configured to allocate the communication resources available to one of the cells between the terminals in that cell using: (i) the macro-scheduler's allocation of communication resources between those terminals; and (ii) a second scheduling algorithm. | 10-01-2015 |
Christopher Kevan Lowe, Cambridgeshire GB
Patent application number | Description | Published |
---|---|---|
20120086551 | Headset Ear Detection - A device capable of providing information to a user through a plurality of different alerting signals, includes a sensing system capable of sensing indications that the device is in a first particular physical relationship to the user's body; an alerting system capable of conveying information to the user through a plurality of different alerting signals, the alerting signals including: a first set of alerting signals and a second set of alerting signals that are such as to be less noticeable to the user if the device is in the first particular physical relationship to the user's body than the first set of alerting signals, the device further including comprising a controller responsive to the sensing system and configured to estimate from the indications whether the device is in the first particular physical relationship to the user's body, and while it is to control the alerting system so as to suppress the provision of information to the user through the second set of alerting signals. | 04-12-2012 |
Christopher R. Lowe, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20110177540 | MUTANT LUCIFERASE - An isolated recombinant luciferase having luciferase activity. The recombinant luciferase has an amino acid sequence which differs from the wild-type luciferase from | 07-21-2011 |
20120007607 | SENSING SYSTEM AND METHOD - A sensing system comprises a material having a matrix structure in which a plurality of sensing elements are embedded, the sensing elements having electron distribution and/or transport properties that change in response to a change in a physical or chemical property of the material. The sensing system further comprises a receiver, including an antenna, the receiver arranged to receive a source RF signal and a returned RF signal, the returned RF signal being received from the material. A change in the electron distribution and/or transport properties of the sensing elements cause the source RF signal to change, such that a change in a property of the material can be determined from the returned RF signal. A corresponding method of sensing a change in a property of a material is also provided. | 01-12-2012 |
20140072649 | Immunized Camel Milk-Based Composition for the Treatment or Prevention of Gastrointestinal Infections - The present invention relates to a novel composition with milk of immunized camelid, particularly, ( | 03-13-2014 |
20140170686 | MUTANT LUCIFERASE - An isolated recombinant luciferase having luciferase activity. The recombinant luciferase has an amino acid sequence which differs from the wild-type luciferase from | 06-19-2014 |
20140170687 | MUTANT LUCIFERASE - An isolated recombinant luciferase having luciferase activity. The recombinant luciferase has an amino acid sequence which differs from the wild-type luciferase from | 06-19-2014 |
Christopher Robin Lowe, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20090017469 | Use of Holographic Sensor - The present invention relates to a process for the detection of an analyte in a sample, comprising a) bringing the sample into contact with a first ligand which binds specifically to the analyte and which is immobilised on a substrate, and b) prior to or subsequent to step (a), bringing the sample into contact with a second ligand which binds specifically to the analyte and which includes a label: wherein the substrate comprises a holographic sensor comprising a support medium having a hologram disposed therein or thereon and the label causes an optical property of the sensor to change by interaction of the sensor with the label or, following the additional step of contacting the substrate with a reagent, by interaction of the sensor with a species produced by reaction of the label with the reagent, thereby indicating the presence of bound analyte. | 01-15-2009 |
20090021697 | Ophthalmic Device Comprising a Holographic Sensor - An ophthalmic device which comprises a holographic element comprising a medium comprising a phenylboronic acid group and, disposed therein, a hologram, wherein an optical characteristic of the element changes as a result of a variation of a physical property of the medium, and wherein the variation arises as a result of interaction between the medium and an analyte present in an ocular fluid. | 01-22-2009 |
20090098467 | Holographic Sensor Based on a Volume Hologram in a Porous Medium - A sensor for the detection of an analyte, comprising a holographic element comprising a medium and a hologram disposed throughout the volume of the medium, wherein an optical characteristic of the hologram changes as a result of a variation of a physical property occurring throughout the volume of the medium, wherein the medium is obtainable by formation in situ in the presence of a pore-forming agent, wherein the agent is not present in the sensor or does not react with the analyte and the sensor. | 04-16-2009 |
20100021936 | Sensor for Spores - A sensor for spores, comprises spore-binding ligands and, on or within the body of the sensor, a material that is responsive to Ca-DPA (calcium-dipicolinic acid) but not to a (or another) germinant. | 01-28-2010 |
20100167416 | Novel Boronate Complex and Its Use in a Glucose Sensor - A sensor comprises respective acceptor and donor compounds immobilised in or on a matrix including a glucose-binding boronate and a cationic species, whereby the spacing between the acceptor and donor compounds is reduced in the presence of glucose. For example a holographic sensor comprises a glucose-binding boronate and a cationic species held within the sensor. | 07-01-2010 |
20110187026 | Method of Production of a Holographic Sensor - A method for the production of a holographic sensor which comprises a support medium supporting a reflection hologram wherein the support medium interacts with its physical or chemical environment to create an optical response which is a change in one or more optical properties of the hologram, the method comprising the steps of: a) introducing a colloidal dispersion of a recording material into the support medium; and b) ablating the colloidal particles of the recording material using a pulsed laser to form the holographic element in the support medium. The method of production can be used to introduce a reflection holographic grating into a hydrophobic support medium, in particular, polydimethylsiloxane (PDMS), which possesses an extraordinary ability to swell in the presence of both liquid and/or gaseous low molecular weight hydrocarbons and organic solvents and thus has many applications as a holographic sensor. | 08-04-2011 |
20110286064 | OPHTHALMIC DEVICE COMPRISING A HOLOGRAPHIC SENSOR - An ophthalmic device which comprises a holographic element comprising a medium comprising a phenylboronic acid group and, disposed therein, a hologram, wherein an optical characteristic of the element changes as a result of a variation of a physical property of the medium, and wherein the variation arises as a result of interaction between the medium and an analyte present in an ocular fluid. | 11-24-2011 |
20120107944 | Holographic Sensor - A sensor for the detection of an analyte comprising a cis-diol moiety, which comprises a holographic element comprising a medium and a hologram disposed throughout the volume of the medium, wherein an optical characteristic of the element changes as a result of a variation of a physical property occurring throughout the volume of the medium, and wherein the medium is a polymer comprising a group of formula (i) | 05-03-2012 |
20130139596 | Sensing System and Method - A sensing system which comprises a material ( | 06-06-2013 |
20140110886 | Method of Production of a Holographic Sensor - A method for the production of a holographic sensor which comprises a support medium supporting a reflection hologram wherein the support medium interacts with its physical or chemical environment to create an optical response which is a change in one or more optical properties of the hologram, the method comprising the steps of: a) introducing a colloidal dispersion of a recording material into the support medium; and b) ablating the colloidal particles of the recording material using a pulsed laser to form the holographic element in the support medium. The method of production can be used to introduce a reflection holographic grating into a hydrophobic support medium, in particular, polydimethylsiloxane (PDMS), which possesses an extraordinary ability to swell in the presence of both liquid and/or gaseous low molecular weight hydrocarbons and organic solvents and thus has many applications as a holographic sensor. | 04-24-2014 |
Christopher Robin Lowe, Cambridge Cambridgeshire GB
Patent application number | Description | Published |
---|---|---|
20100203650 | BIOMOLECULE BINDING LIGANDS - The invention provides biomolecule binding ligands, collections of biomolecule binding ligands, and their use in the purification of biological mixtures and in the identification of ligands having an affinity for a substance. The ligand is a compound of formula (III) or a compound of formula (IV): wherein for compounds of formula (I) one of R | 08-12-2010 |
David Lowe, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20090298167 | INTERLEUKIN-21 RECEPTOR BINDING PROTEINS - The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing and/or treating IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders. | 12-03-2009 |
20120264919 | INTERLEUKIN-21 RECEPTOR BINDING PROTEINS - The present invention provides binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL-21R). The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing and/or treating IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, cancer, and other immune system disorders. | 10-18-2012 |
David Lowe, Royston GB
Patent application number | Description | Published |
---|---|---|
20150274818 | COMPOUNDS AND METHODS FOR TREATING PAIN - This disclosure provides compositions and methods for controlling pain. In particular the disclosure provides a method for controlling pain comprising co-administration of an NGF antagonist and a TNFα antagonist. The NGF antagonist and the TNFα antagonist can be separate molecules or part of a multifunctional polypeptide, e.g., a multispecific binding molecule that comprises an NGF antagonist domain and a TNFα antagonist domain. This disclosure also provides multifunctional polypeptides, e.g., multispecific binding molecules, comprising an NGF antagonist domain, and a TNFα antagonist domain. The method provides improved pain control. Administration of an NGF antagonist and a TNFα antagonist as provided herein can control pain in the subject more effectively than an equivalent amount of the NGF antagonist or the TNFα antagonist administered alone. | 10-01-2015 |
David C. Lowe, Hertfordshire GB
Patent application number | Description | Published |
---|---|---|
20100184960 | Antibodies Against Human IL-22 And Uses Therefor - The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22). The antibodies can act as antagonists of IL-22 activity, thereby modulating immune responses in general, and those mediated by IL-22 in particular. The disclosed compositions and methods may be used for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders. | 07-22-2010 |
20110275790 | Antibodies Against Human IL-22 and Uses Therefor - The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22). The antibodies can act as antagonists of IL-22 activity, thereby modulating immune responses in general, and those mediated by IL-22 in particular. The disclosed compositions and methods may be used for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders. | 11-10-2011 |
20130005033 | ANTIBODIES TO HUMAN IL-22 - The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22). The antibodies can act as antagonists of IL-22 activity, thereby modulating immune responses in general, and those mediated by IL-22 in particular. The disclosed compositions and methods may be used for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders. | 01-03-2013 |
David Christopher Lowe, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20130177555 | Monomeric Polypeptides Comprising Variant FC Regions And Methods Of Use - Provided are monomeric polypeptides comprising variant Fc regions and methods of using them. In certain embodiments, monomeric polypeptides of the invention are fusion proteins. In certain embodiments, monomeric polypeptides of the invention are antibodies. | 07-11-2013 |
20140212429 | BINDING MEMBERS-513 - This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a K | 07-31-2014 |
David Christopher Lowe, Cambridgeshire GB
Patent application number | Description | Published |
---|---|---|
20100221257 | BINDING MEMBERS-513 - This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a K | 09-02-2010 |
20130078717 | BINDING MEMBERS-513 - This invention relates to binding members, especially antibody molecules, specific for interleukin 1 receptor 1 (IL-1R1). For example, isolated binding members specific for IL-1R1 which competes with IL-1 and IL-1Ra for binding to IL-1R1 and binds Il-1R1 with a K | 03-28-2013 |
David John Lowe, Harleston Norfolk GB
Patent application number | Description | Published |
---|---|---|
20080234132 | Microcin B17 Analogs And Methods For Their Preparation And Use - The present invention pertains to synthetic analogues of microcin B17 component units, methods of making and using these analogues, including, for example, as inhibitors of DNA gyrase. More particularly, the present invention pertains to compounds of the Formula wherein: W is independently: —H or a peptide group; Z is independently: —OH or a peptide group; wherein each peptide group, if present, is: an amino acid group and comprises exactly one amino acid, or: a poly(amino acid) group and comprises two or more amino acids; R | 09-25-2008 |
Derek Lowe, Northants GB
Emma Tranquility Lowe, Reddish GB
Patent application number | Description | Published |
---|---|---|
20150030681 | METHOD OF MAKING A HYDROGEL - The present invention relates to a novel protocol for making a hydrogel, which shows increased stability compared to hydrogels of the art, and can be reliably reproduced. The hydrogels produced by the methods of the present invention are preferably three dimensional, and particularly suitable for the culture of stem cells. | 01-29-2015 |
Graham Desmond Lowe, Hayling Island GB
Patent application number | Description | Published |
---|---|---|
20090281427 | Flexible Oesophageal Doppler Monitoring Probe - An oesophageal Doppler monitoring probe is comprised of an elongated flexible shaft having a distal end and a proximal end. In one embodiment, the elongated flexible shaft includes a pitched spring. The probe further includes a probe tip coupled to the distal end, wherein the probe tip includes an ultrasound transducer assembly, and a connector coupled to the proximal end, wherein the connector is configured to electrically couple the monitoring probe to a host processor. In one embodiment, the ultrasound transducer assembly may be configured to detect blood flow characteristics based on the Doppler effect. | 11-12-2009 |
20090281431 | Oesophageal Doppler Monitoring Probe Having a See-Through Boot - An oesophageal Doppler monitoring probe tip for use with an oesophageal Doppler monitoring probe include a first end coupled to an elongated flexible shaft, a molded substrate and an ultrasound transducer assembly affixed to the molded substrate. The probe tip also includes a see-through boot encapsulating the molded substrate and ultrasound transducer assembly. In certain embodiments, the additional use of a see-through sealant material may be used to affix or secure one or more components of the ultrasound transducer assembly in place. | 11-12-2009 |
20110137173 | Method and Apparatus for Hemodynamic Monitoring Using Combined Blood Flow and Blood Pressure Measurement - Combined blood flow and blood pressure measurements are used for the calculation of central vascular blood flow parameters. Blood flow measurements may be made simultaneously with arterial pressure measured either centrally or peripherally and central venous pressure for the monitoring of human subjects. A combined blood flow and blood pressure measurement device for hemodynamic monitoring may include a Doppler ultrasound probe utilizing a continuous wave or pulse wave ultrasound beam for the measurement of blood flow in the aorta, combined with arterial pressure measurement, or signal input from a suitable pressure transducer system from one of either the radial, brachial, dorsalis pedis or femoral artery. The ultrasound probe may comprise either an esophageal or suprasternal ultrasound probe, while the blood pressure measurement may be either an electronic transducer blood pressure sphygmomanometer on the arm, or a finger cot infrared light optical pulse detector. | 06-09-2011 |
Martin Alexander Lowe, Slough GB
Patent application number | Description | Published |
---|---|---|
20090264411 | FUSED THIOPHENE DERIVATIVES AS MEK INHIBITORS - A series of 4,5,6,7-tetrahydrothieno[2,3-c]azepin-8-one derivatives, and analogues thereof, which are substituted in the 2-position by a substituted anilino moiety, being selective inhibitors of human MEK (MAPKK) enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions. | 10-22-2009 |
20150152065 | TNF -Alpha Modulating Benzimidazoles - A series of benzimidazole derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. | 06-04-2015 |
20150203486 | Imidazopyridine Derivatives as Modulators of TNF Activity - A series of imidazo[1,2-a]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. | 07-23-2015 |
Nicholas Lowe, London GB
Patent application number | Description | Published |
---|---|---|
20150050342 | COMPOSITIONS FOR TREATMENT OF SKIN DISORDERS - Compositions are provided comprising: (i) chlorhexidine or a pharmaceutically acceptable salt thereof; (ii) niacinamide or niacin; and (iii) salicylic acid or a pharmaceutically acceptable salt or derivative thereof. The compositions are suitable for use in treating and preventing disorders of the skin. The compositions are also provided in the form of cosmetic products. | 02-19-2015 |
Norman Charles Lowe, Manchester GB
Patent application number | Description | Published |
---|---|---|
20110086790 | COMPOSITION INCLUDING ONE OR MORE HYDROLYTICALLY UNSTABLE COMPONENTS - A composition is provided suitable for use in a cleaning or washing process. The composition includes an activation agent for activating at least one aqueous sensitive component in use. The composition further includes a water soluble builder component and the activation agent is adsorbed onto a surface of the water soluble builder component. | 04-14-2011 |
Philippa Lowe, London GB
Patent application number | Description | Published |
---|---|---|
20150050342 | COMPOSITIONS FOR TREATMENT OF SKIN DISORDERS - Compositions are provided comprising: (i) chlorhexidine or a pharmaceutically acceptable salt thereof; (ii) niacinamide or niacin; and (iii) salicylic acid or a pharmaceutically acceptable salt or derivative thereof. The compositions are suitable for use in treating and preventing disorders of the skin. The compositions are also provided in the form of cosmetic products. | 02-19-2015 |
Phillip Lowe, Tullibody GB
Patent application number | Description | Published |
---|---|---|
20090035876 | Electrochemical Assay - A method of determining the presence or amount of analyte in a fluid sample, which comprises: contacting a fluid sample with a binding reagent that comprises a plurality of cleavable species and wherein said species, when cleaved, are detectable using electrochemical means; separating any binding reagent-analyte complex that forms from the unbound binding reagent; cleaving the cleavable species from the immobilized binding reagent-analyte complex; and detecting the cleaved species using electrochemical means. | 02-05-2009 |
20090130771 | Assay device and method - An assay device includes a first reagent including a magnetic particle and a second reagent including detectable component. The first and second reagent can each independently bind to an analyte in a sample. Applying a magnetic field can selectively concentrate the detectable component in a detection zone, where a detectable change ca be measured and related to the amount of analyte in the sample. | 05-21-2009 |
20100015728 | Assay Device and Method - A method for detecting an analyte can include binding an analyte with a first reagent which is associated with a magnetic particle, allowing analyte to interact with an excess amount of a second reagent capable of interacting with the analyte, and magnetically separating a portion of analyte-bound second reagent from excess second reagent. After the magnetic separation, the interaction of the analyte and the second reagent can be disrupted to produce a detectable form of the second reagent, which can be detected. A device and system suited to performing the method are also described. | 01-21-2010 |
20110053289 | Assay Device and Method - An assay method and device can perform at least one (e.g., at least two) assays on a single aliquot of a sample liquid. The device can mix a sample liquid with assay reagents including magnetically susceptible particles. The device is configured to create a sample liquid-air interface with the sample liquid. The magnetically susceptible particles can be located (via an applied magnetic field) at the liquid-air interface when a second liquid contacts the interface to form a liquid-liquid interface. The magnetic particles travel across the liquid-liquid interface to the second liquid. The magnetically susceptible particles are configured to trans-port an analyte across the interface into the second liquid. An assay for the analyte is performed in the second liquid. An assay for another analyte can also be performed in the sample liquid. | 03-03-2011 |
20130309778 | ASSAY DEVICE AND READER - The present invention relates to a microfluidic based assay system, comprising a disposable assay cartridge and associated reading device, as well as the individual components themselves. The present invention also relates to methods of conducting assays, using the cartridge and device of the invention, as well as kits for conducting assays. | 11-21-2013 |
20140017709 | MICROFLUIDICS BASED ASSAY DEVICE - A subtractive corrective assay device and methodology, whereby ail required binding and label detection reagents are initially located within the detection zone. Application of a magnetic field is used to selectively remove bound label from the detection zone by means of paramagnetic particles. The relationship between measured label concentration before and after the application of a magnetic field within the detection zone is used to accurately measure analyte concentration within the sample. | 01-16-2014 |
Phillip Lowe, North Wood GB
Patent application number | Description | Published |
---|---|---|
20110008813 | ASSAY DEVICE AND METHOD - An assay method and device can perform at least one (e.g., at least two) assays on a single aliquot of a sample liquid. The device can mix a sample liquid with assay reagents including magnetically susceptible particles. The device is configured to create a sample liquid-air interface with the sample liquid. The magnetically susceptible particles can be located (via an applied magnetic field) at the liquid-air interface when a second liquid contacts the interface to form a liquid-liquid interface. The magnetic particles travel across the liquid:liquid interface to the second liquid. The magnetically susceptible particles are configured to transport an analyte across the interface into the second liquid. An assay for the analyte is performed in the second liquid. An assay for another analyte can also be performed in the sample liquid. | 01-13-2011 |
Stuart Bhimsen Lowe, Oxford GB
Patent application number | Description | Published |
---|---|---|
20150223517 | PROCESS FOR USING TOBACCO - The present invention relates to processes for deriving components or products from tobacco biomass. In particular the invention relates to a process for deriving two or more components or products from a single tobacco biomass stock, wherein during the process, at least one component or product, for example nicotine, is extracted from a liquid phase and at least one component or product, for example an organic molecule such as an alcohol, is produced from a solid phase. The invention also relates to products, particularly plastics, synthesised from the organic molecules derived from the biomass stock. | 08-13-2015 |
Thomas Lowe, Oxford GB
Patent application number | Description | Published |
---|---|---|
20100134501 | DEFINING AN ANIMATION OF A VIRTUAL OBJECT WITHIN A VIRTUAL WORLD - A method of defining an animation of a virtual object within a virtual world, wherein the animation comprises performing, at each of a series of time points, an update that updates values for object attributes of the virtual object, the method comprising: allowing a user to define the update by specifying, on a user interface, a structure representing the update, wherein the structure comprises a plurality of items and one or more connections between respective items, wherein each item represents a respective operation that may be performed when performing the update and wherein a connection between two items represents that data output by the operation represented by one of those two items is input to the operation represented by the other of those two items; allowing the user to specify that the structure comprises one or more items in a predetermined category, the predetermined category being associated with a predetermined process such that an item belongs to the predetermined category if performing the respective operation represented by that item requires execution of the predetermined process, wherein said predetermined process may be executed at most a predetermined number of times at each time point; and applying one or more rules that (a) restrict how the user may specify the structure to ensure that performing the defined update does not require execution of the predetermined process more than the predetermined number of times, (b) do not require the user to specify that an item in the predetermined category is at a particular location within the structure relative to other items and (c) do not require the user to explicitly specify which operations need to be performed before execution of the predetermined process when performing the update nor which operations need to be performed after execution of the predetermined process when performing the update. | 06-03-2010 |
Timothy Robert Lowe, Leicester GB
Patent application number | Description | Published |
---|---|---|
20080267701 | Paving System - A paving system comprises an upper paving layer ( | 10-30-2008 |
Timothy Robert Lowe, Hinckley GB
Patent application number | Description | Published |
---|---|---|
20100300019 | Structural Modules With Absorbent Elements For Drainage and Irrigation - A structural module ( | 12-02-2010 |
Vincent A. Lowe, Portishead GB
Patent application number | Description | Published |
---|---|---|
20100320954 | ROTATIONAL VELOCITY MEASUREMENT OF A ROTOR - A system is provided for measuring the rotational velocity of the rotor of an electric motor or generator having (i) a stator with a plurality of circumferentially spaced pole pieces, each pole piece having a corresponding armature winding, and (ii) a rotor with a plurality of circumferentially spaced magnet portions, the armature windings interacting with the magnetic field produced by the magnet portions. The system includes one or more voltage sensing coils. The or each voltage sensing coil is adapted to encircle a respective pole piece of the stator such that a time-varying electromotive force is induced in the voltage sensing coil as the magnet portions of the rotor pass by the pole piece. The system further includes is a detector for detecting the time-varying electromotive force induced in the or each voltage sensing coil, and determining the rotational velocity of the rotor from the time between peaks in the induced electromotive force. | 12-23-2010 |
William Dennis Lowe, Marlow GB
Patent application number | Description | Published |
---|---|---|
20150239577 | RUNWAY ARRANGEMENT - An airport runway arrangement for commercial aircraft is provided. The arrangement comprises a first runway section, a second runway section extending substantially in prolongation of the first runway section and an intermediate section between the first and second runway sections. | 08-27-2015 |
William Patrick Lowe, East Twickenham GB
Patent application number | Description | Published |
---|---|---|
20120036045 | Methods and Systems for Reserving and Completing Purchases - A method of reserving and completing purchases includes transmitting, by a first computing device, a payment authorization code to a second computing device, the payment authorization code associated with an order placed by a user of the second computing device. The method includes receiving, by a transaction management component executing on a third computing device, the payment authorization code from the second computing device. The method includes requesting, by the transaction management component, from the user, a payment to complete the order within a time period. The method includes determining, by the transaction management component, that the user provided the requested payment within the time period. The method includes instructing, by the transaction management component, a retailer transaction management component executing on the first computing device to fulfill the order, responsive to the determination. | 02-09-2012 |